COVID-19 Infection: Epidemiology, Virology, Clinical Features, Diagnosis and Pharmacological Treatment

(E-pub Ahead of Print)

Author(s): Avneet Kaur, Vijay Bhalla, Mohammed Salahuddin, Syed Obaidur Rahman, Faheem Hyder Pottoo*

Journal Name: Current Pharmaceutical Design


Become EABM
Become Reviewer
Call for Editor

Abstract:

Coronavirus was first discovered during the year 1930 and since then vrious coronaviruses like HKU1, MERS-CoV , NL63 and SARS-CoV-2 had been found to infect humans. The COVID-19 pandemic caused by SARS-CoV-2 is spreading at an alarming rate thereby created health emergency around the world. SARS-CoV2 is reportedly to be originated from wet animal market of Wuhan, China. Since then the world is searching for effective way to manage and treat the COVID-19 infection. The infections has already multiplied with several folds compared to the number of person infected by Middle East Respiratory Syndrome Coronavirus and Severe Acute Respiratory Syndrome. In order to fill the gap of knowledge about this virus, several evidences are required to control it so more lives could be saved. The present review is based on the publicly available literature in order to explore the knowledge regarding epidemiology, virology, diagnosis, clinical features, pharmacological and therapeutic ways to treat the novel coronavirus. This can be helpful in offering novel insights and potential therapeutics in fighting this disease.

Keywords: Coronavirus, COVID-19, Cytokine syndrome, SARS-CoV-2, Vaccines, Clinical trial.

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1381612827999210111185608
Price: $95

Article Metrics

PDF: 173